Kimia Biosciences Ltd.

49.87 -0.44 ▼-0.9%

07 May 2024, 04:01:00 PM
Volume: 853

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kimiabiosciences.com
Market Cap 235.95 Cr.
Enterprise Value(EV) 287.16 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -2.80 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.38 Trailing Twelve Months Ending 2023-12
Book Value / Share -0.35 Trailing Twelve Months Ending 2023-12
Price to Book Value -143.76 Calculated using Price: 49.87
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.73 Cr. 47,312,741 Shares
FaceValue 1
About Kimia Biosciences Ltd.
The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Ltd. Delivery

Delivered Qty
Traded Qty

Kimia Biosciences Ltd. Performance

1 Day
-0.87%
1 Week
-1.79%
1 Month
-8.61%
3 Month
+35.11%
6 Month
+31.24%
1 Year
+40.92%
2 Year
+26.09%
5 Year
+46.03%
10 Year

Kimia Biosciences Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -166.09 0 0 0 243.83 16.47 32.19 -22.22 -91.91
Return on Capital Employed (%) -135.77 -216.82 -18.3 11.83 16.94 8.94 16.13 -2.32 -14.3
Return on Assets (%) -33.62 -92.83 -11.72 4.76 6.24 1.83 5.31 -3.44 -8.28

Kimia Biosciences Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 -4 -5 2 6 13 18 15 5 0
Non Curr. Liab. 1 7 9 25 29 34 37 32 35 33
Curr. Liab. 3 1 7 31 30 39 51 62 76 62
Minority Int.
Equity & Liab. 5 4 12 58 65 86 107 109 117 96
Non Curr. Assets 4 4 10 15 18 25 35 36 35 34
Curr. Assets 1 1 2 43 48 61 70 73 83 62
Misc. Exp. not W/O
Total Assets 5 4 12 58 65 86 107 109 117 96

Kimia Biosciences Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 2 0 1 76 94 106 133 125 129 97
Other Income 1 0 1 1 1 1 2 1 1 2
Total Income 2 0 2 77 95 107 135 126 130 99
Total Expenditure -4 -4 -2 -74 -88 -102 -124 -124 -134 -107
PBIDT -1 -3 0 3 7 5 11 2 -4 -8
Interest 0 -1 0 -1 -2 -3 -3 -4 -4 -5
Depreciation 0 0 0 -1 -1 -2 -2 -3 -3 -3
Taxation 0 0 0 0 0 0 0 1 3 4
Exceptional Items -1 -1
PAT -2 -4 -1 2 4 1 5 -4 -9 -13
Adjusted EPS -2 -5 -1 1 3 0 1 -1 -2 -3

Kimia Biosciences Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 -6 -1 -7 -3 0 6 8 -7
Cash Fr. Inv. 0 0 0 -6 -2 -2 -9 -14 -1 -3
Cash Fr. Finan. 0 0 6 7 10 4 8 8 -8 10
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 1 0 0 1 0 0

Kimia Biosciences Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94
Public 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Kimia Biosciences Ltd. Announcements

Tue, 07 May 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/ Madam In reference to the earlier intimation dated 06.05.2024 pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The Company has received the confirmation from Registrar & Transfer Agent Beetal Financial Computer Services Private Limited regarding the issuance of duplicate share certificates.
Mon, 06 May 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/ Madam Pursuant to Regulation 39(3) of SEBI ( Listing Obligation and Disclosure Requirements) Regulations 2015. The Company has received the intimation from our Registrar & Transfer Agent Beetal Financial Services Private Limited regarding the request received for issuance of duplicate share certificates.
Fri, 19 Apr 2024
Compliance Certificate Pursuant To Regulation 40(9) Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations 2015.
Dear Sir/ Madam Pursuant to Regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed herewith certificate issued by Practicing Company Secretary.

Kimia Biosciences Ltd. Technical Scans

Tue, 07 May 2024
Opening at High Opening at High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months

Kimia Biosciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 363,535.24 1,515.35 -0.9%
Cipla Ltd. 112,058.35 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. 104,414.05 6,257.60 -0.6%
Divi's Laboratories Ltd. 103,844.67 3,911.40 -1.3%
Zydus Lifesciences Ltd. 98,676.34 980.85 -3.9%
Mankind Pharma Ltd. 88,830.49 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. 88,586.40 2,619.35 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.82 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-12 30.22 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.97 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 75.09 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.18 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-12 51.43 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.29 2,619.35 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-12 4.33 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.89 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.97 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.24 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-12 10.00 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.39 2,619.35 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,619.35 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,619.35 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,619.35 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,619.35 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,515.35 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,387.20 -2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,257.60 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,911.40 -1.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 980.85 -3.9%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,217.25 -3.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,619.35 -3.6%

Kimia Biosciences Ltd. FAQ's

What is Kimia Biosciences share price?

Can I buy Kimia Biosciences shares now?

What is the Market Cap of Kimia Biosciences?

What is the 52 Week High and Low of Kimia Biosciences?

What is the trend of Kimia Biosciences share price?